# Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's Disease

> **NCT05777031** · PHASE4 · RECRUITING · sponsor: **University of Miami** · enrollment: 22 (estimated)

## Conditions studied

- Peyronie Disease
- Sexual Dysfunctions, Psychological
- Genital Diseases, Male

## Interventions

- **DRUG:** Collagenase Clostridium Histolyticum (CCH)

## Key facts

- **NCT ID:** NCT05777031
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-02
- **Primary completion:** 2027-01-15
- **Final completion:** 2027-01-15
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2026-03-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05777031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05777031, "Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's Disease". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05777031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*